M
Margaret J. Neff
Researcher at University of Washington
Publications - 23
Citations - 5374
Margaret J. Neff is an academic researcher from University of Washington. The author has contributed to research in topics: Lung injury & Intensive care. The author has an hindex of 16, co-authored 23 publications receiving 4982 citations. Previous affiliations of Margaret J. Neff include Harborview Medical Center.
Papers
More filters
Journal ArticleDOI
Incidence and Outcomes of Acute Lung Injury
Gordon D. Rubenfeld,Ellen Caldwell,Eve Peabody,Jim Weaver,Diane P. Martin,Margaret J. Neff,Eric J. Stern,Leonard D. Hudson +7 more
TL;DR: It is estimated that each year in the United States there are 190,600 cases of acute lung injury, which are associated with 74,500 deaths and 3.6 million hospital days, considerably higher than previous reports have suggested.
Journal ArticleDOI
Cytomegalovirus reactivation in critically ill immunocompetent patients.
Ajit P. Limaye,Katharine A. Kirby,Gordon D. Rubenfeld,Wendy M. Leisenring,Eileen M. Bulger,Margaret J. Neff,Nicole S. Gibran,Meei Li Huang,Tracy K. Santo Hayes,Lawrence Corey,Michael Boeckh +10 more
TL;DR: Preliminary findings suggest that reactivation of CMV occurs frequently in critically ill immunocompetent patients and is associated with prolonged hospitalization or death.
Journal ArticleDOI
Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients
Avery B. Nathens,Margaret J. Neff,Gregory J. Jurkovich,Patricia Klotz,Katherine Farver,John T. Ruzinski,Frank Radella,Iris Garcia,Ronald V. Maier +8 more
TL;DR: To determine the effectiveness of early, routine antioxidant supplementation using α-tocopherol and ascorbic acid in reducing the rate of pulmonary morbidity and organ dysfunction in critically ill surgical patients.
Journal ArticleDOI
Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients
TL;DR: The early administration of antioxidant supplementation using &agr;-tocopherol and ascorbic acid reduces the incidence of organ failure and shortens ICU length of stay in this cohort of critically ill surgical patients.
Journal ArticleDOI
A Phase II Randomized Placebo-Controlled Trial of Omega-3 Fatty Acids for the Treatment of Acute Lung Injury
Renee D. Stapleton,Thomas R. Martin,Noel S. Weiss,Joseph J. Crowley,Stephanie J. Gundel,Avery B. Nathens,Saadia R. Akhtar,John T. Ruzinski,Ellen Caldwell,J. Randall Curtis,Daren K. Heyland,Timothy R. Watkins,Polly E. Parsons,Julie M. Martin,Mark M. Wurfel,Teal S. Hallstrand,Kathryn A. Sims,Margaret J. Neff +17 more
TL;DR: Fish oil did not reduce biomarkers of pulmonary or systemic inflammation in patients with acute lung injury, and the results do not support the conduct of a larger clinical trial in this population with this agent.